MY133368A - Process for preparing pharmaceutical compositions for use with soft gelatin formulations - Google Patents

Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Info

Publication number
MY133368A
MY133368A MYPI20014820A MYPI20014820A MY133368A MY 133368 A MY133368 A MY 133368A MY PI20014820 A MYPI20014820 A MY PI20014820A MY PI20014820 A MYPI20014820 A MY PI20014820A MY 133368 A MY133368 A MY 133368A
Authority
MY
Malaysia
Prior art keywords
active ingredient
pharmaceutically active
concentration
soft gelatin
pharmaceutical compositions
Prior art date
Application number
MYPI20014820A
Inventor
Charles Tindal Stephen
Clive Webster Christopher
Christine Ferdinando Josephine
Lewis Jacqueline
Original Assignee
R P Scherer Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R P Scherer Tech Inc filed Critical R P Scherer Tech Inc
Priority to MYPI20014820A priority Critical patent/MY133368A/en
Publication of MY133368A publication Critical patent/MY133368A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE INVENTION DISCLOSED HEREIN IS A PROCESS FOR INCREASING THE ACHIEVABLE CONCENTRATION OF A PHARMACEUTICALLY ACTIVE INGREDIENT RELATIVE TO FILL COMPOSITION VISCOSITY FOR DOSAGE UNITS. THE PROCESS IS PARTICULARLY USEFUL IN THE PREPARATION OF SOFT GELATIN CAPSULES CONTAINING IBUPROFEN, NAPROXEN, INDOMETHACIN, AND ACETAMINOPHEN, AS THE PHARMACEUTICALLY ACTIVE INGREDIENT. AS A RESULT OF THE PROCESS, LESSER QUANTITIES OF COMPOSITION INGREDIENTS OTHER THAN THE PHARMACEUTICALLY ACTIVE INGREDIENT ARE NEEDED TO ACCOMPLISH THE SAME THERAPEUTICALLY EFFECTIVE DOSAGE, THEREBY SIGNIFICANTLY INCREASING THE CONCENTRATION OF THE PHARMACEUTICALLY ACTIVE INGREDIENT RESULTING IN EITHER A REDUCTION IN OVERALL FILL VOLUME AND DOSAGE UNIT SIZE OR AN INCREASE IN CONCENTRATION OF PHARMACEUTICALLY ACTIVE INGREDIENT PER DOSAGE FORM.
MYPI20014820A 2001-10-17 2001-10-17 Process for preparing pharmaceutical compositions for use with soft gelatin formulations MY133368A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20014820A MY133368A (en) 2001-10-17 2001-10-17 Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20014820A MY133368A (en) 2001-10-17 2001-10-17 Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Publications (1)

Publication Number Publication Date
MY133368A true MY133368A (en) 2007-11-30

Family

ID=78573158

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20014820A MY133368A (en) 2001-10-17 2001-10-17 Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Country Status (1)

Country Link
MY (1) MY133368A (en)

Similar Documents

Publication Publication Date Title
AU2431702A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
MY118371A (en) Tetrahydrolipstatin containing compositions
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
CA2251886A1 (en) An oral pharmaceutical formulation containing ibandronate
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
AP2003002763A0 (en) Controlled release formulations for oral administration
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
MXPA04004907A (en) Acetaminophen compositions.
GEP20043377B (en) Pharmaceutical Complex
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
DE69800210D1 (en) Anhydrous lactulose-based product
AU2019203288A1 (en) Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
HUP0100634A2 (en) Pharmaceutical preparations comprising pentaerytritol tetranitrate
MY145885A (en) Controlled release formulations for oral administration
NO964775L (en) Solid pharmaceutical adenosine-containing preparation
DE50311479D1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS